Theresa Wingrove, SVP OF REGULATORY AFFAIRS at ImmunoGen, Inc. (IMGN), sold 24,054 shares at $29.30 ($705K) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Scheduled sale ($705k) by SVP OF REGULATORY AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.30 | 12,027 | $352K | 50.0% |
| 2 | $29.30 | 12,027 | $352K | 50.0% |
| Total | $29.30 avg | 24,054 | $705K | 100% |
| Filing → |
| IMGN | SELL | 2023-12-01 | $9.7M | — | Filing → |
| IMGN | SELL | 2023-11-17 | $5.3M | — | Filing → |
| IMGN | SELL | 2023-11-08 | $650K | — | Filing → |